Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Clinical trial NCT04356742 · COMPLETED
Trial details
- NCT number
- NCT04356742
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2022-02-23
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.